Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glaukos Corp
(NY:
GKOS
)
125.28
+2.51 (+2.04%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Glaukos Corp
< Previous
1
2
3
4
5
6
7
Next >
10 Analysts Have This To Say About Glaukos
July 10, 2024
Via
Benzinga
This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
July 10, 2024
Via
Benzinga
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
July 10, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
June 14, 2024
From
Glaukos Corporation
Via
Business Wire
Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
May 22, 2024
Via
Benzinga
Analyst Ratings For Glaukos
April 08, 2024
Via
Benzinga
5 Analysts Have This To Say About Glaukos
March 22, 2024
Via
Benzinga
Glaukos Announces Participation in Upcoming Investor Conferences
May 28, 2024
From
Glaukos Corporation
Via
Business Wire
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
May 02, 2024
Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%.
Via
Benzinga
Topics
Earnings
Exposures
Financial
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
May 02, 2024
Via
Benzinga
Glaukos: Q4 Earnings Insights
February 21, 2024
Via
Benzinga
Earnings Scheduled For February 21, 2024
February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.
Via
Benzinga
Analyst Ratings For Glaukos
February 16, 2024
Via
Benzinga
Unveiling 7 Analyst Insights On Glaukos
December 21, 2023
Via
Benzinga
GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024
May 01, 2024
GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Glaukos Announces First Quarter 2024 Financial Results
May 01, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces the Release of its 2023 Sustainability Report
April 16, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
April 10, 2024
From
Glaukos Corporation
Via
Business Wire
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
April 03, 2024
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
April 03, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
April 01, 2024
From
Glaukos Corporation
Via
Business Wire
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
February 22, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
January 31, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
January 09, 2024
From
Glaukos Corporation
Via
Business Wire
Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst
December 21, 2023
Shares of Glaukos Corp (NYSE: GKOS) continued to climb in early trading on Thursday, after the company’s iDose TR (travoprost intracameral implant) received U.S.
Via
Benzinga
Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
December 21, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 20, 2023
From
Glaukos Corporation
Via
Business Wire
iDoseTR Approval Sets Stage for Glaukos' Game-Changing Product, Surpassing Market Expectations, Says Analyst
December 15, 2023
Thursday, the FDA approved Glaukos Corporation's (NYSE: GKOS) marketing application for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog...
Via
Benzinga
Exposures
Product Safety
Dow Extends Rally As Treasury Yields Tank
December 14, 2023
The Dow Jones Industrial Average is charging full speed ahead, up 78 points this afternoon after yesterday closing at record highs, on the heels of the Federal Reserve's rate decision.
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.